Skip to main content
Signal8

LadRx Corporation (LADX)

Sector: Biotechnology

LadRx Corporation logo

LadRx Corporation

OTC:LADXHealthcare
$0.0003
CLOSED
Mkt Cap$149
EV-
Float492K
O/S497K
VOL3K sh
$ Vol$1
RVOL2.55×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.00030.00030.00030.00033,003
Nov 11, 20260.00030.00030.00030.00031,176
Oct 8, 20260.00020.00020.00020.0002342
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
About

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.

The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor.

Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer.

In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates.

The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022.

The company was incorporated in 1985 and is headquartered in Los Angeles, California.

Key Metrics
Market Cap$149
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryBiotechnology
Exchange--
CountryUSUS
IPO Date-
Shares Outstanding496,667
Authorized Shares
Float491,706
52-Week Range
$0.0000$0.1200
$0.0003(0th percentile)
Volume
Average Daily Volume2.09K
3.00K today vs 2.09K avg(+44%)

30d Avg

2.09K

60d Avg

1.02K

90d Avg

905

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

LadRx Corporation (OTC: LADX) traded at $0.0003 on Nov 16, 2026. 52-week range: $0.0000 to $0.1200. The company is in the Healthcare sector (Biotechnology).